SUN PHARMACEUTICAL INDUSTRIES LTD. - Sun Pharmaceutical Industries Ltd reply to clarification sought by the exchange

	< Back
15 May 2015
The Exchange had sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing in Business Standard on May 14, 2015 titled "Ranbaxy accused of gaming FDA rules to thwart rivals"<BR><BR>Sun Pharmaceutical Industries Ltd replied stating "Meijer, Inc. filed a purported class action complaint on May 12, 2015 against the Company and its certain subsidiaries, alleging antitrust and RICO Act violations in connection with Ranbaxy securing market exclusivity as part of the FDA's approval for certain products. Our Company is reviewing the complaint and has no comments at this time."
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us